Mirena vs Kyleena: Comparing Hormonal IUDs for Long-Term Birth Control
Mirena and Kyleena are both T-shaped hormonal intrauterine devices (IUDs) made by Bayer that release levonorgestrel directly into the uterus. Both are FDA-approved for up to 5 years of contraception with over 99% efficacy. The key differences lie in hormone dose, device size, and clinical applications. Mirena delivers a higher dose (52mg total) and is also approved for treating heavy menstrual bleeding. Kyleena has a lower dose (19.5mg total), a slightly smaller frame, and may produce fewer systemic hormonal side effects while allowing most women to keep lighter periods.
Hormone Dose: Why It Matters
The most important difference between Mirena and Kyleena is their levonorgestrel content. Mirena contains 52mg and initially releases about 20mcg/day, declining to about 10mcg/day after 5 years. Kyleena contains 19.5mg and initially releases about 17.5mcg/day, declining to about 9mcg/day.
This dose difference has real clinical implications. Mirena's higher hormone load causes more significant endometrial thinning, which is why it effectively treats heavy menstrual bleeding (menorrhagia) and often leads to amenorrhea. About 20% of Mirena users stop having periods within the first year, and up to 60% by 5 years.
Kyleena's lower dose still provides excellent contraception but with less endometrial suppression. Most Kyleena users experience lighter, shorter periods rather than no periods. About 12% achieve amenorrhea by year 1. For women who want the convenience of an IUD but prefer to maintain some semblance of a menstrual cycle, Kyleena may feel more natural.
The lower systemic hormone exposure with Kyleena may also mean fewer hormone-related side effects like headaches, mood changes, acne, or breast tenderness—though individual responses vary significantly.
Period Effects: How Each IUD Changes Your Cycle
Mirena is known for dramatically reducing menstrual bleeding. Many women experience progressively lighter periods over the first 3–6 months, followed by very light spotting or complete amenorrhea. This makes Mirena an excellent therapeutic option for women with heavy periods, endometriosis, or adenomyosis. It's one of the few contraceptive methods that can actually treat a medical condition (menorrhagia) while preventing pregnancy.
Kyleena typically results in lighter, shorter periods but most women continue to have some monthly bleeding. The initial 3–6 months may include irregular spotting (common with all hormonal IUDs), but this usually settles into a predictable lighter pattern. Some women appreciate maintaining a regular cycle as confirmation they are not pregnant.
Important: Both IUDs commonly cause irregular spotting in the first 3–6 months after insertion. This is normal and not a reason to remove the device. The bleeding pattern stabilizes over time. If heavy or prolonged bleeding persists beyond 6 months, contact your healthcare provider.
How to Choose Between Mirena and Kyleena
Choose Mirena if:
- You have heavy menstrual bleeding (menorrhagia) and want treatment
- You'd prefer to reduce or eliminate your period entirely
- You have endometriosis or adenomyosis
- You want off-label extended use beyond 5 years (data supports up to 8 years)
- You need both contraception and menstrual management
Choose Kyleena if:
- You're sensitive to hormones and want the lowest effective dose
- You prefer to maintain lighter, regular periods
- You have a smaller uterus and want a more comfortable fit
- You're a nulliparous woman (never been pregnant) and want easier insertion
- You've had hormonal side effects (mood changes, headaches) with other methods
Both IUDs are safe, highly effective, and reversible. Fertility returns quickly after removal of either device. Your healthcare provider can help assess which is best based on your anatomy, menstrual history, and health goals.
Compare Your Personalized Switch Plan
Frequently Asked Questions
Sources
- Mirena (levonorgestrel-releasing intrauterine system) FDA Prescribing Information, Bayer
- Kyleena (levonorgestrel-releasing intrauterine system) FDA Prescribing Information, Bayer
- ACOG Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices
Don't miss price changes
GLP-1 prices are changing — stay ahead
Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.
- Price increase warnings before they hit
- Savings card and coupon alerts
- New switching guidance and availability updates
No spam. Unsubscribe anytime. We never share your email.
Get Birth Control Prescribed Online
Skip the waiting room — get your prescription delivered.
Vetted reproductive health providers, including Mirena.
MedSwitcher may earn a commission from some providers. Full disclosure. This does not affect our recommendations. Our recommendations are based on clinical data, not partnerships.